IP Library Granted Patent US 10,119,118
Granted Patent B2
US 10,119,118 · App. 15/187,425 · Granted Nov 6, 2018

Modified serum-free cell culture medium

Inventors: Itzcoatl A. Pla (Worcester, MA); Joseph G. Matuck (Worcester, MA); John C. Fann (Shrewsbury, MA); Christof Schulz (Ayer, MA); Nichole A. Roy (Worcester, MA); David F. Bruton (Enfield, CT); James McIntire (Castro Valley, CA); Yu-hsiang D. Chang (Solana Beach, CA); Thomas Seewoester (Simi Valley, CA)
Assignee: AbbVie Inc.
C12N5/0037C07K16/00C07K16/241C07K16/244C07K16/2869C12N5/0031C12N5/0603C07K2317/14C07K2317/21C12N2500/24C12N2500/25C12N2500/30C12N2500/32C12N2500/34C12N2500/38C12N2500/50C12N2500/60C12N2500/74C12N2500/76C12N2500/90C12N2501/10C12N2501/33C12N2510/02C12N2511/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,119,118
App. No.
15/187,425
Granted
Nov 6, 2018
Kind
B2
Abstract

The invention describes improved methods and compositions for producing a recombinant protein, e.g., an antibody, in mammalian cell culture. In addition, the invention provides improved cell culture media, including improved production media, feed solutions, and combination feeds, which may be used to improve protein productivity in mammalian cell culture.

Claims (4)

1. A serum-free cell culture medium comprising Part A, Part B, and Part C, wherein

a) Part A consists essentially of a modified basal medium, wherein the modified basal medium is JRH 67411;

b) Part B consists essentially of an inorganic iron source; and

c) Part C comprises a recombinant growth factor; a buffer; and osmolarity regulator; an energy source; and at least two different non-animal hydrolysates.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2016
From: MCINTIRE, JAMES; CHANG, YU-HSIANG DAVID; SEEWOESTER, THOMAS
To: BASF AKTIENGESELLSCHAFT
Reel/Frame 040603/0927 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2016
From: PLA, ITZCOATL A.; MATUCK, JOSEPH G.; FANN, JOHN C.; SCHULZ, CHRISTOF; ROY, NICHOLE A.; BRUTON, DAVID F.
To: ABBOTT LABORATORIES
Reel/Frame 040604/0825 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2016
From: BASF AKTIENGESELLSCHAFT
To: ABBOTT LABORATORIES
Reel/Frame 040866/0553 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2016
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 040866/0731 →
Continuity (8)
Continuation 15069456 · Mar 14, 2016
Continuation 14920452 · Oct 22, 2015
Continuation 14157460 · Jan 16, 2014
Division 13308075 · Nov 30, 2011
Continuation 11901274 · Sep 13, 2007
Provisional Application 60876374 · Dec 21, 2006
Provisional Application 60845158 · Sep 13, 2006
Related Publication 20170130191A1 · May 11, 2017
Cited By (1)
US 12,454,675